Pfizer Claims Pharmaceutical's Latest Big Prize
Interactive Video
•
Business, Health Sciences, Engineering, Biology
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
The video discusses Pfizer's recent acquisitions, highlighting the $13.7 billion Medivation deal and the failed Allergan merger. It explores why oncology is a hot market for acquisitions, driven by scientific advancements and pricing dynamics. The potential split of Pfizer is debated, with analysts suggesting recent deals may not influence this decision. Other potential acquisition targets in the oncology space, such as Biomarin and Insight, are also mentioned.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What impact did the failed allergy deal have on Pfizer's acquisition strategy?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
Which companies are mentioned as potential targets for Pfizer in the oncology space?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
